Literature DB >> 12082530

Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1).

Otávia L Caballero1, Vicente Resto, Meera Patturajan, Daoud Meerzaman, Ming Zhou Guo, James Engles, Robert Yochem, Edward Ratovitski, David Sidransky, Jin Jen.   

Abstract

PGP9.5 (UCH-L1) is a member of the ubiquitin C-terminal hydrolase (UCH) family of proteins that is expressed in neuronal tissues. Our previous studies have shown that PGP9.5 was highly expressed in primary lung cancers and lung cancer cell lines. Additionally, the frequency of PGP9.5 over expression increases with tumor stage, indicating that PGP9.5 may play a role in lung cancer tumorigenesis. We used the yeast two-hybrid system to identify proteins that interact with PGP9.5. We show that PGP9.5 interacts with at least three proteins, one of which is JAB1, a Jun activation domain binding protein that can bind to p27(Kip1) and is involved in the cytoplasmic transportation of p27(Kip1) for its degradation. We also show that PGP9.5 is associated with JAB1 in vitro and in vivo; and that both proteins can be a part of a heteromeric complex containing p27(Kip1) in the nucleus in lung cancer cells. Furthermore, under serum-restimulation, nuclear translocation of both PGP9.5 and JAB1 coincides with a reduced level of p27(Kip1) in the nucleus. In contrast, when cells are contact inhibited, both PGP9.5 and JAB1 became more perinuclear and cytoplasmic in localization while p27(Kip1) was present only in the nucleus. Therefore, PGP9.5 may contribute to p27(Kip1) degradation via its interaction and nuclear translocation with JAB1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082530     DOI: 10.1038/sj.onc.1205390

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions.

Authors:  K Y Chu; H Li; K Wada; J D Johnson
Journal:  Diabetologia       Date:  2011-10-25       Impact factor: 10.122

2.  Ubiquitin C-terminal hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation.

Authors:  Mark J Henderson; Neeraj Vij; Pamela L Zeitlin
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

3.  Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity.

Authors:  Tomohiro Kabuta; Takeshi Mitsui; Masaki Takahashi; Yuuki Fujiwara; Chihana Kabuta; Chiho Konya; Yukihiro Tsuchiya; Yusuke Hatanaka; Kenko Uchida; Hirohiko Hohjoh; Keiji Wada
Journal:  J Biol Chem       Date:  2013-03-29       Impact factor: 5.157

4.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

5.  Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1.

Authors:  Anna E Cartier; Stevan N Djakovic; Afshin Salehi; Scott M Wilson; Eliezer Masliah; Gentry N Patrick
Journal:  J Neurosci       Date:  2009-06-17       Impact factor: 6.167

6.  Acute damage by naphthalene triggers expression of the neuroendocrine marker PGP9.5 in airway epithelial cells.

Authors:  Thomas T Poulsen; Xu Naizhen; Hans S Poulsen; R Ilona Linnoila
Journal:  Toxicol Lett       Date:  2008-07-17       Impact factor: 4.372

Review 7.  Protein partners of deubiquitinating enzymes.

Authors:  Karen H Ventii; Keith D Wilkinson
Journal:  Biochem J       Date:  2008-09-01       Impact factor: 3.857

8.  Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.

Authors:  Wen-Juan Wang; Qing-Quan Li; Jing-Da Xu; Xi-Xi Cao; Hai-Xia Li; Feng Tang; Qi Chen; Jin-Ming Yang; Zu-De Xu; Xiu-Ping Liu
Journal:  Int J Oncol       Date:  2008-11       Impact factor: 5.650

9.  Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.

Authors:  Anjali Bheda; Julia Shackelford; Joseph S Pagano
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

10.  Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.

Authors:  Barbara Seliger; Diana Handke; Elisabeth Schabel; Juergen Bukur; Rudolf Lichtenfels; Reinhard Dammann
Journal:  J Transl Med       Date:  2009-10-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.